Innovassynth Investments Ltd
₹ 29.3
0.72%
24 May
- close price
About
Incorporated in 2008, Innovassynth Investments Ltd is a holding and investment company
Key Points
- Market Cap ₹ 71.1 Cr.
- Current Price ₹ 29.3
- High / Low ₹ 36.0 / 19.1
- Stock P/E
- Book Value ₹ 14.0
- Dividend Yield 0.00 %
- ROCE -0.96 %
- ROE -1.90 %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- Promoter holding is low: 36.3%
- Company has a low return on equity of -2.23% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Finance Industry: Finance & Investments
Loading peers table ...
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Upcoming result date: 29 May 2024
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.18 | 0.11 | 0.17 | 0.20 | 0.26 | 0.26 | 0.29 | 0.38 | 0.34 | 0.28 | 0.38 | 0.38 | 0.34 | |
| Operating Profit | -0.18 | -0.11 | -0.17 | -0.20 | -0.26 | -0.26 | -0.29 | -0.38 | -0.34 | -0.28 | -0.38 | -0.38 | -0.34 |
| OPM % | |||||||||||||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | |
| Interest | 0.02 | 0.00 | 0.00 | 0.04 | 0.06 | 0.08 | 0.11 | 0.16 | 0.21 | 0.24 | 0.27 | 0.30 | 0.34 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.20 | -0.11 | -0.17 | -0.24 | -0.32 | -0.34 | -0.38 | -0.54 | -0.55 | -0.52 | -0.65 | -0.66 | -0.68 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| -0.20 | -0.11 | -0.17 | -0.24 | -0.32 | -0.34 | -0.38 | -0.54 | -0.55 | -0.52 | -0.65 | -0.66 | -0.68 | |
| EPS in Rs | -0.08 | -0.05 | -0.07 | -0.10 | -0.13 | -0.14 | -0.16 | -0.22 | -0.23 | -0.21 | -0.27 | -0.27 | -0.28 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -23% |
| 3 Years: | -7% |
| TTM: | 1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 34% |
| 3 Years: | 53% |
| 1 Year: | 29% |
| Return on Equity | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -2% |
| 3 Years: | -2% |
| Last Year: | -2% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 24.28 | 24.28 | 24.28 | 24.28 | 24.28 | 24.28 | 24.28 | 24.28 | 24.28 | 24.28 | 24.28 | 24.28 | 24.28 |
| Reserves | -0.40 | -0.50 | -0.68 | -0.92 | -1.23 | -1.58 | -1.95 | -3.76 | -4.23 | -4.42 | 10.70 | 10.04 | 9.69 |
| 0.00 | 0.10 | 0.30 | 0.45 | 0.65 | 0.93 | 1.18 | 1.92 | 2.23 | 2.50 | 2.85 | 3.24 | 3.47 | |
| 0.02 | 0.02 | 0.01 | 0.07 | 0.16 | 0.24 | 0.36 | 0.26 | 0.42 | 0.65 | 0.93 | 1.22 | 1.35 | |
| Total Liabilities | 23.90 | 23.90 | 23.91 | 23.88 | 23.86 | 23.87 | 23.87 | 22.70 | 22.70 | 23.01 | 38.76 | 38.78 | 38.79 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 23.85 | 23.85 | 23.85 | 23.85 | 23.85 | 23.85 | 23.85 | 22.59 | 22.66 | 22.99 | 38.76 | 38.76 | 38.76 |
| 0.05 | 0.05 | 0.06 | 0.03 | 0.01 | 0.02 | 0.02 | 0.11 | 0.04 | 0.02 | 0.00 | 0.02 | 0.03 | |
| Total Assets | 23.90 | 23.90 | 23.91 | 23.88 | 23.86 | 23.87 | 23.87 | 22.70 | 22.70 | 23.01 | 38.76 | 38.78 | 38.79 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.20 | -0.09 | -0.17 | -0.19 | -0.22 | -0.19 | -0.14 | -0.49 | -0.36 | -0.28 | -0.32 | -0.34 | |
| 0.00 | -0.03 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.21 | 0.09 | 0.19 | 0.15 | 0.20 | 0.19 | 0.15 | 0.58 | 0.29 | 0.25 | 0.32 | 0.36 | |
| Net Cash Flow | 0.01 | -0.03 | 0.05 | -0.04 | -0.02 | 0.00 | 0.01 | 0.08 | -0.07 | -0.03 | 0.00 | 0.02 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | ||||||||||||
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | ||||||||||||
| Working Capital Days | ||||||||||||
| ROCE % | -0.75% | -0.46% | -0.71% | -0.84% | -1.09% | -1.10% | -1.15% | -1.65% | -1.52% | -1.25% | -1.26% | -0.96% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 19h
- Board Meeting Intimation for Approval Of Audited Financial Results And The Financial Statement Of The Company For The Quarter And Year Ending March 31, 2024. 20 May
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 30 Apr
- Compliance As Per Regulations 40 (9) & (10) Of The SEBI (LODR) Regulations, 2015, For The Financial Year Ended March 31, 2024. 19 Apr
- Compliance Certificate For The Year Ended On 31St March 2024 As per Regulation 7(3) Of SEBI (LODR) Regulations, 2015 18 Apr
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Business Associate:[1][2][3]
Company invested in Innovassynth Technologies (India) Limited (~31.79%), which is its Associate from 12 February 2022. ITIL is R&D and technology-based Organization engaged in developing, scaling up and manufacturing of specialty chemicals and pharmaceutical Intermediates. Key focus business areas are customs synthesis, contract research & manufacturing of specialty chemicals, toll manufacture of chemicals and similar businesses. It also supplies protected nucleosides and modified phosphonamidites used for clinical, diagnostic and therapeutic oligonucleotides applications. On 12th February 2022, Managing Director of Innovassynth Technologies Ltd was appointed as Managing Director of company resulting into establishment of significant influence over ITIL. Company has not diversified its investment in other entities except ITIL